To comprehensively characterize mutations that affect gliomas we enriched for ZEB1 by combining low grade glioma data, GBM patient data including previously reported ZEB1 mutations13, 14, and exome sequencing data from Cedars-Sinai Medical Center. Here, ZEB1 is linked to central nervous system cancer.